Delivery Order SPE2DB25D3306-SPE2DB25FUCQF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,140.38 to AmerisourceBergen Drug Corp for ProQuad vials on August 11, 2025, with a completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order supports federal medical procurement needs and is being performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunity against measles, mumps, rubella, and varicella, making this order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,696.30 to AmerisourceBergen Drug Corp for ProQuad vials on September 19, 2025, with an ultimate completion date of October 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $8,354.50 under a firm fixed-price contract. The award was made on July 25, 2025, with an ultimate completion date of August 15, 2025. This is a non-set-aside, competitively awarded delivery order, with performance to take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,745.76 to AmerisourceBergen Drug Corp for ProQuad vials on June 16, 2025, with an ultimate completion date of July 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine protecting against measles, mumps, rubella, and varicella, representing a critical...
- The Defense Logistics Agency awarded a $10,853.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of September 25, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The award was made competitively without set-aside designation to the Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $2,740.40 with an ultimate completion date of August 19, 2025. This firm fixed price, competitively awarded delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,687.48 to AmerisourceBergen Drug Corp for ProQuad vials, with a completion date of September 30, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to the contractor's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,437.40 to AmerisourceBergen Drug Corp for ProQuad vials. This is a firm fixed-price, competitively awarded contract with a completion date of August 4, 2025, with performance to take place at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine protecting against measles, mumps, rubella, and varicella, and this delivery order represents a routine pharmaceutical supply need within the...
- The Defense Logistics Agency awarded a $13,367.20 delivery order to AmerisourceBergen Drug Corp for ProQuad vials on September 16, 2025, with an ultimate completion date of October 7, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing a...
- The Defense Logistics Agency awarded a delivery order valued at $6,055.26 to AmerisourceBergen Drug Corp for ProQuad vials on August 5, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is located in...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCQFDelivery Order
The Defense Logistics Agency (DLA) awarded a $1,687.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials on August 14, 2025, with a completion date of September 5, 2025. ProQuad is a combination vaccine providing immunization against measles, mumps, rubella, and varicella. This non-set-aside award was competitively procured and reflects AmerisourceBergen's ongoing role as a critical pharmaceutical supplier to federal medical systems, particularly supporting military and veteran healthcare needs through the DLA's extensive medical supply chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and running through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major for-profit pharmaceutical distributor and healthcare solutions provider that maintains consistent competitive success across the federal medical procurement landscape through its demonstrated capability to fulfill diverse medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/14/25 |